Balyasny Asset Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Balyasny Asset Management’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-111,541	Closed	-$1.27M	–	3376
2024 Q3	$1.27M	Buy	111,541 +77,757	+230%	+$780K	﹤0.01%	1870
2024 Q2	$241K	Buy	+33,784	New	+$258K	﹤0.01%	2286
2023 Q4	–	Sell	-28,061	Closed	-$265K	–	2988
2023 Q3	$265K	Sell	28,061 -164,618	-85%	-$1.98M	﹤0.01%	1952
2023 Q2	$2.69M	Buy	+192,679	New	+$3.28M	0.01%	1281
2021 Q2	–	Sell	-77,322	Closed	-$1.41M	–	2446
2021 Q1	$1.41M	Sell	77,322 -172,678	-69%	-$2.87M	0.01%	1155
2020 Q4	$2.88M	Buy	+250,000	New	+$2.29M	0.02%	791

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Balyasny Asset Management's CDMO Position: Q4 2024 in Review

Balyasny Asset Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2024, closing a stake of 111,541 shares — an estimated $1.27M sold.

Balyasny Asset Management first reported a position in CDMO in Q4 2020 and held it in 6 quarters. The position peaked at $2.88M in Q4 2020. 195 funds tracked by Wall St. Rank hold CDMO as of Q4 2024.

Balyasny Asset Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Balyasny Asset Management sold 111,541 Avid Bioservices, Inc. Common Stock shares in Q4 2024, an estimated $1.27M.
Balyasny Asset Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
Balyasny Asset Management's Avid Bioservices, Inc. Common Stock position peaked at $2.88M in Q4 2020.
195 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2024.

Based on Balyasny Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.